(Reuters) - Genetic Technologies Ltd's (GENE.O) (GTG.AX) U.S.-listed shares closed up 30 percent on Friday, capping a two-and-a-half week spate of heavy trading during which its market valuation increased by 533 percent.
U.S. shares in the Australian genetic testing company closed at $8.04 on Friday on no apparent news during the day. They rose as much as 54.6 percent earlier in the session to touch a nearly 12-month high of $9.49 per share.
17:59 How Sears CEO Lampert cashes in as stores cash out21
21:05 Houston home building rises while commercial projects fall in February20
19:53 Costco Wholesale expands test of home grocery delivery through new third-party service20
13:08 Tesla raises $1.2 billion, 20 percent more than planned20